Affiliation:
1. Department of Pharmaceutical Analysis, KVSR Siddhartha College of Pharmaceutical Sciences, Pinnamaneni Polyclinic Road, Siddhartha Nagar, Vijayawada - 520010, Andhra Pradesh, India.
Abstract
An accurate and stability indicating HPLC method was developed for the estimation of Ivabradine in tablets. The chromatographic analysis was performed on Shimadzu LC-10AT VP system, C18 Column (150 x 4.6mm; 5μ) with mobile phase consisting of acetonitrile: 10Mm ammonium acetate buffer (pH 7.2) in the ratio of 60:40 v/v, at a flow rate of 1.0mL/min and eluents monitored at 285nm. The method was validated for linearity, accuracy, precision, robustness and application for assay as per ICH guidelines. The retention time of ivabradine was 2.224 min. The calibration curves of peak area versus concentration, which was linear from 10 - 50μg/mL for ivabradine, had regression coefficient (r2) greater than 0.999. The method had the requisite accuracy, precision, and robustness for determination of ivabradine in tablets. The proposed method can be successfully employed in routine quality control for the analysis of ivabradine in tablets.
Subject
Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference14 articles.
1. KD Tripathi. Essentials of Medical Pharmacology, 7th Edi. Jaypee Brothers Medical Publishers Pvt. Ltd., New Delhi, India 2013.
2. Ferrari R, Pavasini R, Camici PG, Crea F, Danchin N, Pinto F, Manolis A, Marzilli M, Rosano GMC, Lopez-Sendon J and Fox K. Anti-anginal drugs–beliefs and evidence: systematic review covering 50 years of medical treatment. European Heart Journal. 2019; 40(2): 190–194.
3. Daniel A Jones, Adam Timmis and Andrew Wragg. Novel drugs for treating angina. British Medical Journal. 2013; 347: f4726.
4. Ivabradine. https://www.drugbank.ca/drugs/DB09083
5. (Assessed on 16 December 2018)